U.K.’s Technology Strategy Board and Indian government sign program of co-operation

Tuesday, March 19, 2013 11:30 AM

The Technology Strategy Board (TSB) and the Indian government’s Department of Science and Technology have agreed to undertake a joint program to support innovative U.K. and Indian businesses working together on the commercialization of research in a range of key areas, including energy and healthcare. The ‘Program of Co-operation’ was signed at an international reception held at the InnovateUK conference in London.

The agreement is the first international partnership the Technology Strategy Board has signed outside of Europe. The TSB and the Indian Global Innovation and Technology Alliance (GITA), sponsored by the Indian government, will support U.K. and Indian businesses and academics in joint R&D and innovation projects over three years. The TSB will commit up to approximately $7.5 million to the program.

“These programs not only help build and strengthen links between countries, but will help build the international partnerships between businesses so vital in today’s global economy,” said Iain Gray, CEO of the TSB.

The program is expected to expand further over time, for the mutual benefit of businesses from both countries. India’s rapidly growing economy provides opportunities for innovative U.K. businesses. By working with similar Indian businesses, U.K. companies can understand the needs of the market. The TSB will help them build partnerships and support joint, collaborative R&D and innovation projects.

The TSB is the U.K.’s innovation agency. Its goal is to accelerate economic growth by stimulating and supporting business-led innovation. Sponsored by the Department for Business, Innovation and Skills, it brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs